Twin Tree Management’s United Therapeutics UTHR Stock Holding History

Twin Tree Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,200	Closed	-$585K	–	1751
2025 Q4	$585K	Hold	1,200	–	–	0.01%	1099
2025 Q3	$503K	Sell	1,200 -200	-14%	-$67.3K	﹤0.01%	1280
2025 Q2	$402K	Buy	+1,400	New	+$418K	﹤0.01%	1459
2017 Q3	–	Sell	-5,500	Closed	-$714K	–	1178
2017 Q2	$714K	Buy	+5,500	New	+$686K	0.01%	703
2017 Q1	–	Sell	-500	Closed	-$72K	–	1276
2016 Q4	$72K	Buy	+500	New	+$63.8K	﹤0.01%	1058
2016 Q2	–	Sell	-3,300	Closed	-$368K	–	1409
2016 Q1	$368K	Buy	3,300 +2,900	+725%	+$367K	0.01%	887
2015 Q4	$63K	Buy	+400	New	+$58.2K	﹤0.01%	1253
2015 Q3	–	Sell	-500	Closed	-$87K	–	1520
2015 Q2	$87K	Buy	+500	New	+$89.9K	﹤0.01%	1173

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Twin Tree Management's UTHR Position: Q2 2025 in Review

Twin Tree Management sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 23 shares — an estimated $6.87K sold.

Twin Tree Management first reported a position in UTHR in Q4 2014 and held it in 24 quarters. The position peaked at $11.4M in Q1 2021. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

Twin Tree Management reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
Twin Tree Management sold 23 United Therapeutics shares in Q2 2025, an estimated $6.87K.
Twin Tree Management first reported a position in United Therapeutics in Q4 2014 and held it in 24 quarters.
Twin Tree Management's United Therapeutics position peaked at $11.4M in Q1 2021.
671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.